Alyeska Investment Group
CNTB

Alyeska Investment Group’s Connect Biopharma Holdings CNTB Stock Holding History

Alyeska Investment Group’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50,000
Closed -$925K – 735
2021
Q1 		$925K Buy
+50,000
New +$851K 0.01% 601

Other funds holding CNTB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
OWP
Old Well Partners Charlotte, North Carolina $4.55M AUM 27.75% 1-Year Est. Return

Alyeska Investment Group's CNTB Position: Q2 2021 in Review

Alyeska Investment Group sold out of Connect Biopharma Holdings (CNTB) in Q2 2021, closing a stake of 50,000 shares — an estimated $925K sold.

Alyeska Investment Group first reported a position in CNTB in Q1 2021 and held it in 1 quarter. The position peaked at $925K in Q1 2021. 16 funds tracked by Wall St. Rank hold CNTB as of Q2 2021.

  • Alyeska Investment Group reported no remaining Connect Biopharma Holdings position as of Q2 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 50,000 Connect Biopharma Holdings shares in Q2 2021, an estimated $925K.
  • Alyeska Investment Group first reported a position in Connect Biopharma Holdings in Q1 2021 and held it in 1 quarter.
  • Alyeska Investment Group's Connect Biopharma Holdings position peaked at $925K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2021.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.